149 related articles for article (PubMed ID: 34046124)
1. Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors.
Agrebi I; Kammoun K; Dammak N; Hachicha J; Boudawara T; Jarraya F; Hmida MB
Pan Afr Med J; 2021; 38():218. PubMed ID: 34046124
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
4. Membranoproliferative glomerulonephritis and circulating cryoglobulins.
Hiramatsu R; Hoshino J; Suwabe T; Sumida K; Hasegawa E; Yamanouchi M; Hayami N; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
Clin Exp Nephrol; 2014 Feb; 18(1):88-94. PubMed ID: 23722669
[TBL] [Abstract][Full Text] [Related]
5. The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
Afolabi H; Zhang BM; O'Shaughnessy M; Chertow GM; Lafayette R; Charu V
Am J Kidney Dis; 2024 Jan; 83(1):79-89. PubMed ID: 37739026
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative glomerulonephritis associated with autoimmune diseases.
Zand L; Fervenza FC; Nasr SH; Sethi S
J Nephrol; 2014 Apr; 27(2):165-71. PubMed ID: 24500888
[TBL] [Abstract][Full Text] [Related]
7. A descriptive study of individuals with membranoproliferative glomerulonephritis.
Lu DF; McCarthy AM; Lanning LD; Delaney C; Porter C
Nephrol Nurs J; 2007; 34(3):295-302; quiz 303. PubMed ID: 17644874
[TBL] [Abstract][Full Text] [Related]
8. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
10. Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie.
Schwertz R; de Jong R; Gretz N; Kirschfink M; Anders D; Schärer K
Acta Paediatr; 1996 Mar; 85(3):308-12. PubMed ID: 8695987
[TBL] [Abstract][Full Text] [Related]
11. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
[TBL] [Abstract][Full Text] [Related]
12. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
[TBL] [Abstract][Full Text] [Related]
13. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in children with membranoproliferative glomerulonephritis type I.
García-de la Puente S; Orozco-Loza IL; Zaltzman-Girshevich S; de Leon Bojorge B
Pediatr Nephrol; 2008 Jun; 23(6):929-35. PubMed ID: 18297315
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of membranoproliferative glomerulonephritis in KwaZulu-Natal, South Africa is unrelated to hepatitis C virus infection.
Madala ND; Naicker S; Singh B; Naidoo M; Smith AN; Rughubar K
Clin Nephrol; 2003 Aug; 60(2):69-73. PubMed ID: 12940606
[TBL] [Abstract][Full Text] [Related]
16. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
17. Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan.
Kawamura T; Usui J; Kaseda K; Takada K; Ebihara I; Ishizu T; Iitsuka T; Sakai K; Takemura K; Kobayashi M; Koyama A; Kanemoto K; Sumazaki R; Uesugi N; Noguchi M; Nagata M; Suka M; Yamagata K
Clin Exp Nephrol; 2013 Apr; 17(2):248-54. PubMed ID: 22971963
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival.
de Paula LC; Mazzali M; de Sousa MV
Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
20. [Etiologies of end-stage renal disease of children in Tunisia].
Jellouli M; Boussetta A; Abidi K; Maalej B; Naija O; Hammi Y; Zarrouk C; Mahfoudh A; Gargah T
Nephrol Ther; 2016 Jun; 12(3):166-70. PubMed ID: 26906230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
